Free press releases distribution network?

Agency / Source: Becton, Dickinson and Company

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



BD Issues 2010 Sustainability Report - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the publication of its 2010 Sustainability Report
BD Issues 2010 Sustainability Report

 

PRZOOM - /newswire/ - Franklin Lakes, NJ, United States, 2011/05/19 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the publication of its 2010 Sustainability Report. NYSE: BDX

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The report reaffirms the commitment of BD's 29,000 dedicated associates worldwide to pursuing the Company's purpose,"Helping all people live healthy lives," and doing so in a way that is centered on balancing the "triple-bottom-line" – achieving strong economic performance, promoting environmental stewardship and advancing social responsibility.

"In 2010, we continued to observe the strong connections between global health challenges and global environmental issues – and the role that BD can play in making progress in both areas," said Edward J. Ludwig, Chairman and Chief Executive Officer. "We continue to make progress and believe that our sustainability strategy drives our creativity. It helps us to be more innovative with regard to our actions, products, services and collaborations, which in turn drive growth and operating excellence."

BD's commitment to helping to provide affordable, accessible medical technologies that help address fundamental healthcare needs has been embedded in BD’s culture since the Company’s founding in 1897. Today, BD also recognizes the importance of strong environmental performance, and aspires to be recognized as the most environmentally responsible company in its industry.

The 2010 Sustainability Report highlights BD's priorities and performance in areas including:

• Society: BD is focused on making contributions to society through its worldwide business operations, including the medical devices, instrument systems and reagents that it manufactures and sells, and is dedicated to improving people’s health throughout the world. BD supplements these contributions by giving time, talent and resources to improve global health standards and access to healthcare for all communities. The report highlights BD's strategic collaborations.
• Fundamental Healthcare Needs: BD's strategy is to increase sustainable revenue growth by serving as a global leader in developing and applying technologies to solve emerging, sometimes underappreciated, but important and fundamental healthcare problems. The report highlights BD's work to address important healthcare issues, such as healthcare-associated infections (HAIs), women's health and cancer, and diabetes.
• Product Responsibility: BD products play a key role in the discovery, diagnosis and treatment of disease, through an approach that includes integrating safety-engineering features into our products design. The report highlights continued efforts on healthcare worker and patient safety, as well as BD’s approach to working with suppliers on sustainability.
• Associates: The success of BD's business depends on the creativity, innovation and commitment of the 29,000 people it employs in more than 50 countries around the world. The report highlights BD’s commitment to associate health and safety, learning and development, and diversity and inclusion.
• The Environment: BD has a clear strategy to reduce its environmental footprint while supporting the efforts of its customers and suppliers to do the same, through an approach that extends throughout the integrated supply chain. The report highlights progress toward BD’s 2015 Sustainability Targets, and the achievement of meeting three of these targets – hazardous waste reduction, renewable energy use and water reduction – ahead of schedule.

2010 Awards and Recognition highlights include:

• BD has been included on the Dow Jones Sustainability World Index for five consecutive years.
• BD was ranked #2 in the Healthcare industry and #24 overall in Newsweek's 2010 Green Rankings.
• BD has been named one of the "World's Most Ethical Companies" by Ethisphere since 2007.
• BD was awarded a 2010 Green Power Leadership Award in the Green Power Purchaser category by the U.S. Environmental Protection Agency (EPA).

BD's 2010 Sustainability Report is available online at bd.com/sustainability.

About BD
BD (bd.com), a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.

Contact:
Monique N. Dolecki, Investor Relations
P: (201) 847-5453 / E: monique_dolecki[.]bd.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Becton, Dickinson and Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BD Issues 2010 Sustainability Report

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
BD |
Contact: Colleen T. White - BD.com 
201-847-5369 colleen_white[.]bd.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Becton, Dickinson and Company securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Becton, Dickinson and Company / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Al Rowaad Advocates & Legal Consultants

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Intrinsic Executive Search Ltd







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today